"New Alzheimer’s detection strategies combat falling dementia diagnosis rates" - touchNEUROLOGY talks to Professor Bengt Winblad about research presented at EAN Congress

In this expert interview, conducted at the 2025 EAN Congress, Prof. Bengt Winblad discusses dementia diagnoses falling post-COVID, and explores how expanding biomarker use, timely clinical assessment, and integrated therapeutic strategies, including both pharmacological and lifestyle interventions are reshaping clinical practice. He underscores the importance of balancing early detection with diagnostic caution to minimise misclassification and promote responsible patient care Poster presented at EAN 2025: Impact of the COVID-19 Pandemic on Dementia Diagnoses in Sweden: Trends from 2015 to 2023. Abstract: 530620. Check out the full discussion, here:

 https://touchneurology.com/insight/a-new-era-in-early-alzheimers-diagnosis-the-power-of-plasma-biomarkers/